References
[1] S. E. S. Abbas, R. F. George, E. M.Samir, M. M. A. Aref, H. A. Abdel-Aziz, "Synthesis and Anticancer Activity of Some Pyrido[2,3-d]Pyrimidine Derivatives as Apoptosis Inducers and Cyclin-Dependent Kinase Inhibitors." Future Medicinal. Chemistry, Vol 11 No 18, pp 2395–2414, 2019.
[2] O. O.Ajani, J. T.Isaac, T. F.Owoeye, A. A.Akinsiku, " Exploration of the Chemistry and Biological Properties of Pyrimidine as a Privilege Pharmacophore in Therapeutics". International Journal of biological chemistry, Vol 9, No 4, 148–177, 2015.
[3] M.Said, K Abouzid,. A Mouneer,. A.Ahmedy, A Osman,. "Synthesis and Biological Evaluation of New Thiazolopyrimidines." Archives of Pharmacal Research, Vol 27, No 5, pp 471–477, 2004
[4] A.Gaafar, A.Aly, K. M. Abu-Zied, A. E. Abdel-Rahman, M .Helmy " Chemical Synthesis of Some Novel 6-Aminouracil-2-Thiones and Their Glycoside Analogues." Egyptian Journal of Chemistry.,Vol 59 , No 5, pp 779–797, 2016.
[5] X.-H. Liu, Q. Wang, Z.-H. Sun, D. E.Wedge, J. J .Becnel, A. S. Estep, C.-X. Tan, J.-Q. Weng, "Synthesis and Insecticidal Activity of Novel Pyrimidine Derivatives Containing Urea Pharmacophore against Aedes Aegypti". Pest Management Science., Vol 73, No 5,pp 953–959, 2017.
[6] H. S. A. Elzahabi, E. S. Nossier, N. M. Khalifa, R. A. Alasfoury, M. A.El-Manawaty, "Anticancer Evaluation and Molecular Modeling of Multi-Targeted Kinase Inhibitors Based Pyrido[2,3- d ]Pyrimidine Scaffold." Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 33, No 1, pp 546–557, 2018.
[7] C.-A. Lefebvre, E. Forcellini, S. Boutin, M.-F. Côté, C.- R.Gaudreault, P. Mathieu, P. Lagüe, J.-F Paquin,. "Synthesis of Novel Substituted Pyrimidine Derivatives Bearing a Sulfamide Group and Their in Vitro Cancer Growth Inhibition Activity." Bioorganic & Medicinal Chemistry Letter.,Vol 27 No 2, pp 299–302, 2017
[8] N. S. M. Ismail, G. M. E.Ali, D. A.Ibrahim, R. A. T.Serya, D. A. Abou El Ella, "Medicinal Attributes of Pyrazolo[1,5-a]Pyrimidine Based Scaffold Derivatives Targeting Kinases as Anticancer Agents." Future Journal of Pharmaceutical Sciences,Vol 2, pp 60–70, 2016
[9] A. K. Parmar, M. R. Patle. "Regression Analysis and Docking Study of Pyrimidine Based Compounds as anti-Tuberculosis Therapeutic Agents". International Journal of Scientific Research in Biological Sciences, Vol.6, Issue.2, pp.133-143, 2019
[10] S. S.Karki, K. Panjamurthy, S.Kumar, M. Nambiar, S. A. Ramareddy, K. K.Chiruvella, S. C. Raghavan, "Synthesis and Biological Evaluation of Novel 2-Aralkyl-5-Substituted-6-(4?-Fluorophenyl)-Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives as Potent Anticancer Agents." European Journal of Medicinal Chemistry.,Vol 46, No 6,pp 2109–2116, 2011
[11] W. Wang, B.Zhao, C. Xu, W. Wu, "Synthesis and Antitumor Activity of the Thiazoline and Thiazine Multithioether." IInternational Journal of Organic Chemistry, Vol 2, No 02, pp 117–120, 2012
[12] S. N. Sirakanyan, D. Spinelli, A. Geronikaki, V. A. Kartsev, E. K. Hakobyan, A. A. Hovakimyan, "Synthesis of New Derivatives of Heterocyclic Systems Containing Triazolopyrimidine, Thiazolo[3,2-a]Pyrimidine and Pyrimido[2,1-b] Thiazine Moiety Showing Promising Antimicrobial Activity." Currnt Organic Chemistry., Vol 22, No 26, pp 2576–2588, 2019.
[13] M. A. Ibrahim, S. A.Al?Harbi, E. S. Allehyani, "Construction, Characterization, and Antimicrobial Evaluation of the Novel Heteroannulated Chromeno[2??,3??:6?,5?]Pyrido[2?,3?? d ] [1,3] Thiazolo[3,2? a ]Pyrimidines." Journal of. Heterocycl. Chemistry.,Vol 58 No 1, pp 241–249, 2021.
[14] S. Badshah, A. Naeem, "Bioactive Thiazine and Benzothiazine Derivatives: Green Synthesis Methods and Their Medicinal Importance." Molecules Vol 21, No 8, 1054, 2016,.
[15] A. K.Jain, A.Vaidya, V. Ravichandran, S. K. Kashaw, R. K. Agrawal, "Recent Developments and Biological Activities of Thiazolidinone Derivatives: A Review." Bioorganic & Medicinal Chemistry, Vol 20, No 11,pp 3378–3395, 2012.
[16] A. M. S Youssef,. A. M Fouda,. R. M.Faty, " Microwave Assisted Synthesis of Some New Thiazolopyrimidine and Pyrimidothiazolopyrimidopyrimidine Derivatives with Potential Antimicrobial Activity." Chemistry Central Journal, Vol 12, No 1, pp 50, 2018
[17] E. E Flefel,. M. A.Salama, M.El-Shahat, M. A El-Hashash,. A. F. A El-Farargy "Novel Synthesis of Some New Pyrimidine and Thiazolopyrimidine Derivatives for Anticancer Evaluation." Phosphorus, Sulfur, and Silicon and the Related Elements.,Vol 182 No 8, pp 1739–1756, 2007
[18] S. S.Karki, K Panjamurthy,. S. Kumar,; M. Nambiar, S. A.Ramareddy, K. K.Chiruvella, S. C. Raghavan. "Synthesis and Biological Evaluation of Novel 2-Aralkyl-5-Substituted-6-(4?-Fluorophenyl)-Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives as Potent Anticancer Agents." European Journal of Medicinal Chemistry., Vol 46 No 6, pp 2109–2116, 2011.
[19] D.Kumar, N. Maruthi Kumar, K.-H Chang,. K. Shah, "Synthesis and Anticancer Activity of 5-(3-Indolyl)-1,3,4-Thiadiazoles" European Journal of Medicinal Chemistry,Vol 45, No 10, pp 4664–4668, 2010.
[20] M. N. Noolvi, H. M Patel,. N.Singh, A. K.Gadad, S. S.Cameotra, A. Badiger, "Synthesis and Anticancer Evaluation of Novel 2-Cyclopropylimidazo[2,1-b][1,3,4]-Thiadiazole Derivatives." European Journal of Medicinal Chemistry ,Vol 46, No 9, pp 4411–4418, 2011
[21] M. M Youssef,. M. A Amin,. "Microwave Assisted Synthesis of Some New Thiazolopyrimidine, Thiazolodipyrimidine and Thiazolopyrimidothiazolopyrimidine Derivatives with Potential Antioxidant and Antimicrobial Activity." Molecules,Vol 17 No 8, pp 9652–9667, 2012.
[22] H.LEE, B KIM,. J.AHN, S.KANG, J. LEE, J. SHIN, S. AHN, S. LEE, S. YOON,."Molecular Design, Synthesis, and Hypoglycemic and Hypolipidemic Activities of Novel Pyrimidine Derivatives Having Thiazolidinedione." European Journal of Medicinal Chemistry., Vol 40, No 9, pp 862–874, 2005.
[23] C. J. J.Tack, P. Smits, "Thiazolidinedione Derivatives in Type 2 Diabetes Mellitus." The Netherlands Journal of Medicine, Vol 64 No 6, pp 166–174, 2006.
[24] D. Cai,. Z.-H. Zhang, Y. Chen, X.-J.Yan, S.-T.Zhang, L.-J.Zou, L.-H. Meng, F.Li, B.-J Fu,. "Synthesis of Some New Thiazolo[3,2-a]Pyrimidine Derivatives and Screening of Their in Vitro Antibacterial and Antitubercular Activities." Medicinal Chemistry Research, Vol 25, No 2, pp 292–302, 2016.
[25] S.Wang, X.-H.Yuan, S.-Q.Wang, W.Zhao, X.-B Chen,. B Yu,. "FDA-Approved Pyrimidine-Fused Bicyclic Heterocycles for Cancer Therapy: Synthesis and Clinical Application." European Journal of Medicinal Chemistry, Vol 214,pp 113218, 2021.
[26] M. A.Dickson," Molecular Pathways: CDK4 Inhibitors for Cancer Therapy." Clinical Cancer Research., Vol 20 No 13, pp 3379–3383. 2014
[27] M.Ikuta, K.Kamata, K.Fukasawa, T.Honma, T.Machida,; H. Hirai, I.Suzuki-Takahashi, T. Hayama, S. Nishimura,. "Crystallographic Approach to Identification of Cyclin-Dependent Kinase 4 (CDK4)-Specific Inhibitors by Using CDK4 Mimic CDK2 Protein." Journal of Biological Chemistry, Vol 276, No 29, pp 27548–27554, 2001.
[28] B. B. McConnell, F. J.Gregory, F. J.Stott, E.Hara, G.Peters, "Induced Expression of P16INK4a Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes." Molecular and Cellular Biology, Vol 19 , No 3,pp 1981–1989, 1999.
[29] H. Hirai, N. Kawanishi, Y.Iwasawa, "Recent Advances in the Development of Selective Small Molecule Inhibitors for Cyclin-Dependent Kinases". Current Topics in Medicinal Chemistry,Vol 5, No 2, pp 167–179, 2005.
[30] H.Park, M. S.Yeom, S.Lee "Loop Flexibility and Solvent Dynamics as Determinants for the Selective Inhibition of Cyclin-Dependent Kinase 4: Comparative Molecular Dynamics Simulation Studies of CDK2 and CDK4". ChemBioChem, Vol 5, No 12, pp 1662–1672, 2004.
[31] A. Allouche, Software News and Updates Gabedit — A Graphical User Interface for Computational Chemistry Softwares. Journal of Computational Chemistry, Vol 32, pp 174–182, 2012.
[32] I. V Kulakov,. D. M.Turdybekov, "Synthesis of Bicyclic Pyrimido[2,1-b][1,3]Thiazines Based on 3,4-Dihydropyrimidine-(1h)-2-Thiones." Chemistry of Heterocyclic Compounds.,Vol 46, No 3, pp 342–346, 2010.
[33] K. Undheim,. T. Benneche, "Pyrimidines and Their Benzo Derivatives." In Comprehensive Heterocyclic Chemistry II; Elsevier,; Vol. 6, pp 93–231, 1996.
[34] Henkel, M.; Bach, T. "Annulation of Indoles with 1,n-Dibromoalkanes by a Pd(II)-Catalyzed and Norbornene-Mediated Reaction Cascade." Synthesis (Stuttg).,Vol 52 No 08,pp 1231–1238, 2020.
[35] Molecular Operating Environment (MOE), 2019.01; Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2021. MOE.